Nestlé Health Science to Acquire Nuun (TSG Consumer Partners Stake Sale)

Yellow Wood Partners to Acquire Nestlé Holistic Health Vitamins, Minerals and Supplements Platform for $1B

September 1, 2026

Consumer Products

Yellow Wood Partners agreed to acquire Nestlé’s Holistic Health platform, a vitamins, minerals and supplements (VMS) business, for $1.0 billion. The transaction covers multiple established brands (including Nature’s Bounty, Nuun, Osteo Bi-Flex, and Gard) and related U.S. private-label supplements plus dedicated manufacturing, packaging, warehousing and distribution operations. The deal is expected to close in the first half of 2027, subject to regulatory approvals.

Unilever Acquires Grüns for $1.2 Billion

April 14, 2026

Consumer Products

Unilever has signed an agreement to acquire Grüns, the US greens supplement brand, for $1.2 billion in a full acquisition valued at a significant premium to its prior private valuation. The deal is expected to close in H2 2026, pending regulatory approval, as Unilever looks to scale adherence-first gummy wellness products through its global FMCG distribution.

Danone to Acquire Huel

March 24, 2026

Consumer Products

Danone has entered into a definitive agreement to acquire Huel, a provider of complete, nutritionally balanced meal solutions. The deal is intended to enhance Danone’s presence in functional nutrition and extend its portfolio in the Complete Nutrition space, subject to customary regulatory approvals.

Nestlé Health Science Acquires Majority Stake in Orgain

February 2, 2022

Food & Beverage

Nestlé Health Science has agreed to acquire a majority stake in Orgain, the U.S. plant-based nutrition company, from founder Dr. Andrew Abraham and Butterfly Equity; both sellers will retain minority ownership positions. Dr. Andrew Abraham will remain CEO of Orgain and the deal will let Nestlé Health Science expand its portfolio of clean, plant-based nutrition products globally; the transaction is subject to customary regulatory approvals.

Nestlé Health Science / Société des Produits Nestlé S.A. to acquire Aimmune Therapeutics

August 31, 2020

Pharmaceuticals

Nestlé Health Science (NHSc), via a Nestlé S.A. acquisition subsidiary (Société des Produits Nestlé S.A.), agreed to acquire Aimmune Therapeutics for USD34.50 per share in cash, valuing the company at approximately USD2.6 billion. NHSc already owned ~25.6% of Aimmune; the tender offer is expected to close in Q4 2020 and will expand Nestlé's portfolio with Aimmune's FDA-approved peanut allergy therapy Palforzia.

Nestlé Health Science Acquires Majority Stake in Vital Proteins

June 10, 2020

Food & Beverage

Nestlé Health Science (NHSc), a subsidiary of Nestlé, agreed to acquire a majority stake in Vital Proteins, the US market leader in collagen-based supplements, beverages and food products. Vital Proteins will continue to operate as a standalone business under CEO Kurt Seidensticker, with the deal intended to accelerate global expansion and product innovation.